Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases (Q40513939)

21 September 2017

0 references

Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases (English)

1 reference

21 September 2017

0 references

cardiovascular disease

1 reference

de Bree A

1

1 reference

21 September 2017

Mennen LI

series ordinal

2

1 reference

21 September 2017

Hercberg S

series ordinal

3

1 reference

21 September 2017

Galan P

series ordinal

4

1 reference

21 September 2017

1 May 2004

1 reference

European Journal of Clinical Nutrition

21 September 2017

1 reference

21 September 2017

58

1 reference

21 September 2017

5

1 reference

21 September 2017

732-744

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1601871

21 September 2017

0 references

cites work

Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Effects of short-term dietary administration of marginal levels of vitamin B(6)and fish oil on lipid composition and antioxidant defences in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Methionine metabolism in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Serum folate and chronic disease risk: findings from a cohort of United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Serum folate and risk for coronary heart disease: results from a cohort of US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Fish and omega-3 fatty acid intake and risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Cardiovascular Effects of n-3 Fatty Acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

The oxidant stress of hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Serum Folate and Risk of Fatal Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Homocysteine and atherothrombosis--mechanisms for injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Homocysteine and ischaemic heart disease in the Caerphilly cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Influence of dietary n-3 polyunsaturated fatty acids on plasma lipemic effect of vitamin B6 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Effects of Oral Folic Acid Supplementation on Endothelial Function in Familial Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Low serum folate concentrations are associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

Fish consumption and risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

The composition of the Eskimo food in north western Greenland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Endpoints for homocysteine-lowering trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Dietary modulation of endothelial function: implications for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Diet and reinfarction trial (DART): design, recruitment, and compliance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 y

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

n-3 fatty acids and serum lipoproteins: human studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Serum folate and cardiovascular disease mortality among US men and women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Homocysteine and endothelial dysfunction: a link with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Homocysteine in Greenland Inuits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Fish oil decreases serum homocysteine in hyperlipemic men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Dietary methionine level affects linoleic acid metabolism through phosphatidylethanolamine N-methylation in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Effects of vitamin B-6 on (n-3) polyunsaturated fatty acid metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

The controversy over homocysteine and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Homocysteine, EDRF, and endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature atherothrombotic cerebrovascular disease. A prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

n-3 fatty acids and the prevention of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

The association of vitamin b 12 and folate blood levels with mortality and cardiovascular morbidity incidence in the old old: the Bronx aging study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601871

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1601871

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference